Early Access — free while we kick the tires
EdgarHawk

Zoghbi Huda Y

Director

Director
1 filing analyzed · 1 company · Latest 2026-02-23

Companies

Company Buys Sells Direction
REGENERON PHARMACEUTICALS, INC. REGN 0 12 Net selling

Activity

February 2026
medium
Sell
1,638 shares
$1,279,812
Significance 5/10

Regeneron Director Zoghbi sold 1,638 shares for $1,279,811.86 in 11 separate transactions on 2026-02-19, reducing holdings by -49.0%.

Director Huda Y Zoghbi executed 11 separate sales on 2026-02-19, totaling 1,638 shares (1.6K shares) for $1,279,811.86 at prices ranging from $774.68 to $790.00 with a blended average of $781.33, reducing her post-transaction holdings to 1,703 shares against a pre-transaction position of 3,341 shares. The current share price of $787.04 sits near the top of the 52-week range ($483.07–$812.27) at only -3.1% from the 52-week high, and the stock has appreciated +4.4% over the past 30 days. Regeneron's fundamentals remain solid with net income of $1,460,000,000.00 ($1.5B) on revenue of $3,754,300,000.00 ($3.8B), though annual revenue growth is modest at +1.0%, and the P/E of 15.83 suggests reasonable valuation. Zoghbi's cross-ticker track record shows just 1 prior sell with a 90-day return of +7.7% and a well-timed rate of 0.00%, and her sole prior trade at REGN on 2024-01-02 also posted a 90-day return of +7.7%, indicating the stock has historically risen after her sales rather than fallen.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access